VMP 41949311000001105

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Erythromycin stearate 250mg tablets
BNF code 0501050N0AAAAAA
Virtual Therapeutic Moiety Erythromycin stearate
Date identifier became valid 9 Jun 2023
Previous product identifier 324180003
Basis of preferred name INNM - International Non-proprietary Name (Modified)
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Erythromycin stearate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 372694001
Strength value numerator 250.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Erythrocin 250 tablets (Advanz Pharma)
Erythrocin 250 tablets (CST Pharma Ltd)
Erythromycin stearate 250mg tablets (Ennogen Healthcare International Ltd)
Erythromycin stearate 250mg tablets (Key Pharmaceuticals Ltd)
Virtual Medicinal Product Packs
Erythromycin stearate 250mg tablets 100 tablet
Erythromycin stearate 250mg tablets 28 tablet
Erythromycin stearate 250mg tablets 500 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback